Could a Bronchogenic Cyst Present as an I-131-avid, 99m Tc-Non-Avid Lesion and Mimic Metastatic Thyroid Cancer?

Clin Nucl MedMar 30, 2026 (epub)

Kuan-Chieh Chen, Yi-Ming Chang, Hsing-Hao Su et al.

✦ AI-curated · Sources linked

Case in brief

A 54-year-old man with papillary thyroid carcinoma underwent thyroidectomy and subsequent imaging. A 99m Tc scan showed no thyroid remnant but identified a 3.5-cm left lung lesion with faint uptake on SPECT/CT, raising concern for metastasis. After I-131 therapy, scans on days 3 and 7 showed intense uptake in the lesion. Surgical excision established the diagnosis of a benign bronchogenic cyst; testing was negative for thyroglobulin, TTF-1, BRAF V600E, and PAX-8. The proposed explanation for I-131 uptake was NIS-mediated uptake or mucinous content.

What made this case unusual

The benign bronchogenic cyst showed intense I-131 avidity despite only faint 99m Tc uptake, mimicking metastatic thyroid cancer.

Diagnostic / clinical pearl

I-131 avidity in a lung lesion does not establish thyroid cancer metastasis; consider a bronchogenic cyst and use tissue confirmation when needed to resolve the diagnosis.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pulmonology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.